metastatic renal cell carcinoma
Showing NaN - NaN of 18
Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Renal Cell Carcinoma
- +2 more
- Implantable Microdevice (IMD)
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 17, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Colorectal Carcinoma, Metastatic Malignant Solid Tumor Trial in Canada,
Active, not recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +20 more
- Pembrolizumab
- Ziv-Aflibercept
-
Tampa, Florida
- +8 more
Jan 3, 2023
Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Nephrectomy
- +4 more
-
Birmingham, Alabama
- +414 more
Dec 30, 2022
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Stage III Renal
Recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Axitinib
- Nivolumab
-
Birmingham, Alabama
- +255 more
Aug 24, 2022
Metastatic Renal Cell Carcinoma Trial in Boston (HD IL2)
Completed
- Metastatic Renal Cell Carcinoma
- HD IL2
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jun 20, 2022
Metastatic Renal Cell Carcinoma Trial in Canada, United States (AGS-16C3F, Axitinib)
Completed
- Metastatic Renal Cell Carcinoma
-
Tucson, Arizona
- +25 more
Nov 9, 2021
Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (CB-839, Cabozantinib, Placebo)
Completed
- Advanced Renal Cell Carcinoma
- Metastatic Renal Cell Carcinoma
- CB-839
- +2 more
-
Birmingham, Alabama
- +132 more
Aug 18, 2021
Metastatic Renal Cell Carcinoma Trial in Boston (Pazopanib, Sorafenib, Radium-223)
Completed
- Metastatic Renal Cell Carcinoma
- Pazopanib
- +2 more
-
Boston, Massachusetts
- +1 more
Mar 3, 2020
Metastatic Renal Cell Carcinoma Trial in United States (Hydroxychloroquine, IL-2)
Completed
- Metastatic Renal Cell Carcinoma
-
Maywood, Illinois
- +6 more
Dec 24, 2019
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019
Metastatic Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus)
Completed
- Metastatic Renal Cell Carcinoma
-
Tucson, Arizona
- +36 more
Feb 7, 2019
Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (Standard Treatment,
Terminated
- Advanced Renal Cell Carcinoma
- +2 more
- Standard Treatment
- AGS-003
-
Scottsdale, Arizona
- +124 more
Jun 13, 2018
Metastatic Renal Cell Carcinoma Trial in United States (Ramucirumab)
Completed
- Metastatic Renal Cell Carcinoma
- Ramucirumab
-
San Francisco, California
- +10 more
May 16, 2014
Metastatic Renal Cell Carcinoma, Renal Cell Carcinoma With Sarcomatoid Features Trial in United States (Doxorubicin,
Completed
- Metastatic Renal Cell Carcinoma
- Renal Cell Carcinoma With Sarcomatoid Features
- Doxorubicin
- +3 more
-
Los Angeles, California
- +91 more
Jan 4, 2013